Exploring motivations and barriers in prostate cancer screening: lessons from a volunteer-based MRI screening study
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F25%3A00080515" target="_blank" >RIV/00209805:_____/25:00080515 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1646494/full" target="_blank" >https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1646494/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fpubh.2025.1646494" target="_blank" >10.3389/fpubh.2025.1646494</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Exploring motivations and barriers in prostate cancer screening: lessons from a volunteer-based MRI screening study
Popis výsledku v původním jazyce
Background: Prostate cancer remains a significant public health challenge, an early detection with prostate-specific antigen (PSA) testing and biparametric MRI (bpMRI) can improve outcomes. However, participation hinges on motivational, psychological, and logistical factors. This study examines the motivational profile of men in the ProstaPilot study to guide strategies to increase uptake of state-of-the-art prostate cancer screening programs.Methods: The ProstaPilot study enrolled 423 men who underwent both PSA testing and bpMRI of the prostate. Positive results (PSA GREATER-THAN OR EQUAL TO 3 μg/L or PI-RADS 4-5 lesions) were referred for further urological examination and biopsy. Using an exploratory correlational design, 360 participants completed a detailed questionnaire. Motivational factors were extracted via Principal Component Analysis (PCA) with Oblimin rotation. Perceptions of prostate cancer risk, severity, and prevention were rated on 1-10 scales (10 = most positive).Results: PCA identified four motivational factors explaining 55.6% of variance: (1) concerns about screening (e.g., unnecessary surgery, loss of control); (2) perceived benefits of early detection; (3) social motivation (e.g., contributing to research, role modeling); and (4) barriers (e.g., logistics, embarrassment). Over half (51.1%) had not considered screening before ProstaPilot; others decided over varying timeframes. Participants showed high awareness of prostate cancer and valued early detection, rating screening effectiveness 9.55 +- 0.98 and trust in healthcare professionals 9.6 +- 1.0. Social/familial influences were moderate. Satisfaction was high: likelihood to recommend 9.45 +- 1.22; confidence in continuing participation 9.9 +- 0.39.Conclusion: Highly motivated participants were marked by strong knowledge of prostate cancer screening, trust in healthcare providers, supportive social context, and high personal commitment. These findings support personalized, socially supportive, educational strategies to increase uptake of state-of-the-art screening.
Název v anglickém jazyce
Exploring motivations and barriers in prostate cancer screening: lessons from a volunteer-based MRI screening study
Popis výsledku anglicky
Background: Prostate cancer remains a significant public health challenge, an early detection with prostate-specific antigen (PSA) testing and biparametric MRI (bpMRI) can improve outcomes. However, participation hinges on motivational, psychological, and logistical factors. This study examines the motivational profile of men in the ProstaPilot study to guide strategies to increase uptake of state-of-the-art prostate cancer screening programs.Methods: The ProstaPilot study enrolled 423 men who underwent both PSA testing and bpMRI of the prostate. Positive results (PSA GREATER-THAN OR EQUAL TO 3 μg/L or PI-RADS 4-5 lesions) were referred for further urological examination and biopsy. Using an exploratory correlational design, 360 participants completed a detailed questionnaire. Motivational factors were extracted via Principal Component Analysis (PCA) with Oblimin rotation. Perceptions of prostate cancer risk, severity, and prevention were rated on 1-10 scales (10 = most positive).Results: PCA identified four motivational factors explaining 55.6% of variance: (1) concerns about screening (e.g., unnecessary surgery, loss of control); (2) perceived benefits of early detection; (3) social motivation (e.g., contributing to research, role modeling); and (4) barriers (e.g., logistics, embarrassment). Over half (51.1%) had not considered screening before ProstaPilot; others decided over varying timeframes. Participants showed high awareness of prostate cancer and valued early detection, rating screening effectiveness 9.55 +- 0.98 and trust in healthcare professionals 9.6 +- 1.0. Social/familial influences were moderate. Satisfaction was high: likelihood to recommend 9.45 +- 1.22; confidence in continuing participation 9.9 +- 0.39.Conclusion: Highly motivated participants were marked by strong knowledge of prostate cancer screening, trust in healthcare providers, supportive social context, and high personal commitment. These findings support personalized, socially supportive, educational strategies to increase uptake of state-of-the-art screening.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30204 - Oncology
Návaznosti výsledku
Projekt
<a href="/cs/project/NU22-09-00539" target="_blank" >NU22-09-00539: ProstaPilot. Screening karcinomu prostaty pomocí magnetické rezonance se zkráceným protokolem</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Frontiers in Public Health
ISSN
—
e-ISSN
2296-2565
Svazek periodika
13
Číslo periodika v rámci svazku
November 2025
Stát vydavatele periodika
CH - Švýcarská konfederace
Počet stran výsledku
13
Strana od-do
1646494
Kód UT WoS článku
001627206300001
EID výsledku v databázi Scopus
2-s2.0-105023593298